| Disease | IN 20 PATIENTS AFFECTED BY PROSTATIC ADENOMA, A BLIND, PLACEBO-COMPARED CLINICAL TRIAL WAS PERFORMED, IN ORDER TO EVALUATE THE EFFICACY AND THE TOLERANCE OF AN EXTRACT OF PYGEUM AFRICANUM (200 MG/DIE, BY ORAL ADMINISTRATION). THE TREATMENT WAS
PROLONGED 60 DAYS. AT THE END OF THE TRIAL, A STATISTICALLY SIGNIFICANT DECREASE OF DYSURIC SYMPTOMS (NYCTURIA, POLLAKIURIA, REDUCED STRENGTH OF THE FLOW, ETC.) WAS OBSERVED. NO VARIATIONS WERE PRODUCED BY PLACEBO. A LIMITED
DECREASE OF THE PROSTATIC DIAMETER, EVALUATED BY ULTRASOUND IMAGING, WAS OBTAINED.
A COMMERCIAL PRODUCT, TADENAN, WAS USED. |